Published in OMICS on June 23, 2014
From big data analysis to personalized medicine for all: challenges and opportunities. BMC Med Genomics (2015) 1.04
A Delphi Technology Foresight Study: Mapping Social Construction of Scientific Evidence on Metagenomics Tests for Water Safety. PLoS One (2015) 0.84
Evaluation of Nine Consensus Indices in Delphi Foresight Research and Their Dependency on Delphi Survey Characteristics: A Simulation Study and Debate on Delphi Design and Interpretation. PLoS One (2015) 0.75
Avoidable waste in the production and reporting of research evidence. Lancet (2009) 12.28
First FDA authorization for next-generation sequencer. N Engl J Med (2013) 3.70
The global knowledge society. Science (2012) 1.80
Ancestry and disease in the age of genomic medicine. N Engl J Med (2010) 1.71
How can we help? From "sociology in" to "sociology of" bioethics. J Law Med Ethics (2004) 1.50
H3Africa: a tipping point for a revolution in bioinformatics, genomics and health research in Africa. Source Code Biol Med (2014) 1.32
Ready to put metadata on the post-2015 development agenda? Linking data publications to responsible innovation and science diplomacy. OMICS (2014) 1.24
'Regular science' is inherently political. EMBO Rep (2012) 1.23
Glocal bioethics: When international IRB collaboration confronts local politics. Am J Bioeth (2014) 1.21
Tackling the political determinants of global health. BMJ (2005) 1.01
The epiknowledge of socially responsible innovation. EMBO Rep (2014) 0.99
Coinheritance of sickle cell anemia and α-thalassemia delays disease onset and could improve survival in Cameroonian's patients (Sub-Saharan Africa). Am J Hematol (2014) 0.90
OMICS 2.0: a practice turn for 21(st) century science and society. OMICS (2013) 0.88
Big data and ethics review for health systems research in LMICs: understanding risk, uncertainty and ignorance -- and catching the black swans? Am J Bioeth (2014) 0.87
All the post-genomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health. Per Med (2013) 0.87
Disease advocacy organizations catalyze translational research. Front Genet (2013) 0.84
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet (2004) 15.43
Brain drain and health professionals. BMJ (2002) 7.62
Systems biology and new technologies enable predictive and preventative medicine. Science (2004) 7.59
The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci U S A (2002) 5.98
Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol (2004) 4.91
Human Plasma PeptideAtlas. Proteomics (2005) 4.52
How to achieve international action on falsified and substandard medicines. BMJ (2012) 4.36
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med (2013) 4.27
Clinical trial registration: transparency is the watchword. Lancet (2006) 4.17
A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ (2008) 4.11
A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics (2011) 3.37
Health research systems: a framework for the future. Bull World Health Organ (2003) 3.32
EVIPNet: translating the spirit of Mexico. Lancet (2005) 3.26
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Defining research to improve health systems. PLoS Med (2010) 2.92
Can scientists and policy makers work together? J Epidemiol Community Health (2005) 2.65
Registering clinical trials: an essential role for WHO. Lancet (2004) 2.15
Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilis. PLoS Med (2012) 2.13
The United States of America and scientific research. PLoS One (2010) 1.98
A framework for mandatory impact evaluation to ensure well informed public policy decisions. Lancet (2010) 1.97
Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay. J Neurosurg (2012) 1.97
From Mexico to Mali: a new course for global health. Lancet (2008) 1.93
A human rights approach to an international code of conduct for genomic and clinical data sharing. Hum Genet (2014) 1.90
A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance. PLoS Med (2011) 1.88
Guidance for evidence-informed policies about health systems: rationale for and challenges of guidance development. PLoS Med (2012) 1.81
The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics (2011) 1.79
Management of neural tube defects in a Sub-Saharan African country: the situation in Yaounde, Cameroon. J Neurol Sci (2008) 1.70
Creating a committee C of the World Health Assembly. Lancet (2008) 1.68
From Mexico to Mali: four years in the history of clinical trial registration. J Evid Based Med (2009) 1.68
Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa. Antivir Ther (2009) 1.66
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study. AIDS (2004) 1.63
Health information for all by 2015? Lancet (2004) 1.59
Proteogenomic analysis of Mycobacterium tuberculosis by high resolution mass spectrometry. Mol Cell Proteomics (2011) 1.58
Identification of cavities on protein surface using multiple computational approaches for drug binding site prediction. Bioinformatics (2011) 1.56
Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO). PLoS Comput Biol (2012) 1.55
Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS One (2009) 1.54
WHO facilitates international collaboration in setting standards for clinical trial registration. Lancet (2005) 1.53
Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation. Curr Pharmacogenomics Person Med (2011) 1.49
The need for a European strategy on global health. Scand J Public Health (2006) 1.49
Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics. Mol Cell Proteomics (2006) 1.49
Toward more transparent and reproducible omics studies through a common metadata checklist and data publications. OMICS (2014) 1.49
Proteomic analysis of human prostasomes. Prostate (2003) 1.45
From the Earth Summit to Rio+20: integration of health and sustainable development. Lancet (2012) 1.44
The catechol-O-methyltransferase (COMT) Val158Met polymorphism moderates the effect of antenatal stress on childhood behavioural problems: longitudinal evidence across multiple ages. Dev Med Child Neurol (2011) 1.42
The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia. J Health Popul Nutr (2004) 1.40
Gamma knife radiosurgery inhibits angiogenesis of meningiomas: in vivo rat corneal assay. World Neurosurg (2013) 1.40
Are two internal thoracic artery grafts as safe as one? Experience from Green Lane Hospital. N Z Med J (2012) 1.40
Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy. J Clin Psychopharmacol (2005) 1.39
Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet (2012) 1.38
Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalence. Clin Pharmacokinet (2009) 1.36
Evidence to action in the developing world: what evidence is needed? Bull World Health Organ (2007) 1.34
Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One (2012) 1.31
The distribution and most recent common ancestor of the 17q21 inversion in humans. Am J Hum Genet (2010) 1.31
A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics (2007) 1.31
Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol Cell Proteomics (2005) 1.30
Health literacy--a new concept for general practice? Aust Fam Physician (2009) 1.29
Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM. PLoS One (2011) 1.27
Frequency and clinical genetics of familial dilated cardiomyopathy in Cape Town: implications for the evaluation of patients with unexplained cardiomyopathy. S Afr Med J (2011) 1.27
Filling the gap between knowing and doing. Nature (2003) 1.25
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. Pharmacogenomics (2009) 1.25
From Bangkok to Mexico: towards a framework for turning knowledge into action to improve health systems. Bull World Health Organ (2004) 1.24
Ready to put metadata on the post-2015 development agenda? Linking data publications to responsible innovation and science diplomacy. OMICS (2014) 1.24
'Regular science' is inherently political. EMBO Rep (2012) 1.23
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine. Curr Pharmacogenomics Person Med (2012) 1.23
A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design. Trop Med Int Health (2005) 1.22
Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol Cell Proteomics (2007) 1.20
Leading by example: a culture change at WHO. Lancet (2007) 1.20
Clinical characteristics and outcomes of familial and idiopathic dilated cardiomyopathy in Cape Town: a comparative study of 120 cases followed up over 14 years. S Afr Med J (2011) 1.20
A rare cause of anemia and thrombocytopenia in a newborn: congenital malaria. Turk J Pediatr (2006) 1.19
Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics (2011) 1.19
RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PLoS One (2011) 1.18
Label-free detection techniques for protein microarrays: prospects, merits and challenges. Proteomics (2010) 1.18
Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res (2012) 1.18
ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers. OMICS (2010) 1.17
Overview of mechanisms of cancer chemopreventive agents. Mutat Res (2005) 1.17
The role of tissue reperfusion in the reexpansion injury of the lungs. Eur J Cardiothorac Surg (2002) 1.17
Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population. Fundam Clin Pharmacol (2007) 1.16
Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol (2009) 1.16
Diversity of genome structure in Salmonella enterica serovar Typhi populations. J Bacteriol (2005) 1.15
Triallelic single nucleotide polymorphisms and genotyping error in genetic epidemiology studies: MDR1 (ABCB1) G2677/T/A as an example. Cancer Epidemiol Biomarkers Prev (2007) 1.15
Limits for the scaled average bioequivalence of highly variable drugs and drug products. Pharm Res (2003) 1.14
Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice. J Nutrigenet Nutrigenomics (2011) 1.12
Healthy by law: the missed opportunity to use laws for public health. Lancet (2011) 1.10
Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. PLoS One (2012) 1.10
Building a data sharing model for global genomic research. Genome Biol (2014) 1.09
Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice. Pharmacogenomics (2010) 1.09
A global view of the OCA2-HERC2 region and pigmentation. Hum Genet (2011) 1.08